Andrew Moin

Direttore/Membro del Consiglio presso SAB BIOTHERAPEUTICS, INC.

Consumer Services

Finance

Health Technology

Profilo

Andrew Moin is currently the Director at SAB Biotherapeutics, Inc. and an Analyst at Sessa Capital IM LP.
He is also a Member at The New York Bar Foundation.
Mr. Moin completed his undergraduate degree at Amherst College in 2005 and his graduate degree at Harvard Law School in 2008.

Posizioni attive di Andrew Moin

Società	Posizione	Inizio
SAB BIOTHERAPEUTICS, INC.	Direttore/Membro del Consiglio	05/10/2023
Sessa Capital IM LP Sessa Capital IM LP Investment ManagersFinance Sessa Capital IM LP (Sessa Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by John Petry in 2007. Sessa Capital provides investment advisory and management services on a discretionary basis to private pooled investment vehicles.	Analyst-Equity	01/08/2012
The New York Bar Foundation	Corporate Officer/Principal	-

Tutte le posizioni attive di Andrew Moin

Formazione di Andrew Moin

Harvard Law School	Graduate Degree
Amherst College	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Andrew Moin

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
SAB BIOTHERAPEUTICS, INC.	Health Technology

Aziende private	2
Sessa Capital IM LP Sessa Capital IM LP Investment ManagersFinance Sessa Capital IM LP (Sessa Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by John Petry in 2007. Sessa Capital provides investment advisory and management services on a discretionary basis to private pooled investment vehicles.	Finance
The New York Bar Foundation

Vedi le connessioni aziendali